WAUI
GSK icon

WELLINGTON-ALTUS USA INC.’s GSK GSK Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Hold
688
– – 0.03% 366
2026
Q1 		$36.1K Buy
688
+14
+2% +$759 0.02% 404
2025
Q4 		$33.1K Buy
+674
New +$31.4K 0.02% 376

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s GSK Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. held its GSK (GSK) position steady in Q2 2026 at 688 shares worth $38K. The position accounts for 0.03% of the portfolio, ranked #366.

WELLINGTON-ALTUS USA INC. first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. 1,044 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 688 shares of GSK worth $38K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.03% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #366 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • 1,044 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.